From McKnight’s -[embed_youtubebr />[embed_youtubediv id=”ctl00_ctl00_cphAllPageContent_cphMainContent_ucArticleView_articleBody” class=”articleBody”>[embed_youtubep>Caffeine helps us stay alert. Research suggests it also could slow the progression of Alzheimer’s and Parkinson’s diseases.[embed_youtube/p> [embed_youtubep>In a new collection of studies from around the world on the effects of caffeine on cognitive decline, a number of researchers present evidence of the drug’s ability to slow the progression of these two diseases, as well as a number of other benefits. Here are some of the findings from the 22 new studies: Moderate caffeine intake could provide therapeutic potential for humans, caffeine was associated with lower cognitive decline in women than in men, and caffeine helps reduce the production of amyloid-beta, which is associated with Alzheimer’s. Many of the studies used animal models in the tests.[embed_youtube/p> [embed_youtubep>The [embed_youtubea href=”http://iospress.metapress.com/content/t13614762731/?p=a4364ab69d0d4141a9aaad57f1701056&pi=1″>studies [embed_youtube/a>appear in a special supplement to the recent edition of the Journal of Alzheimer’s Disease, “Therapeutic Opportunities for Caffeine in Alzheimer’s Disease and Other Neurodegenerative Diseases.”[embed_youtubebr />[embed_youtube/p>[embed_youtubep>I prefer Dunkin. How about you?[embed_youtubebr />[embed_youtube/p>[embed_youtube/div>